1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cyclic dinucleotides (CDNs) reversed T cells tolerance in anti-tumor immunotherapy. (4th November 2015) Authors: Fu, Juan; Kim, Young; Kanne, David; Leong, Meredith; Zeng, Qi; Sen, Rupashree; Amstrong, Todd D; Drake, Charles G; Dubensky, Thomas; Pardoll, Drew; Gadkare, Shekhar Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cyclic dinucleotides (CDNs) reversed T cells tolerance in anti-tumor immunotherapy. Issue 2 (December 2015) Authors: Fu, Juan; Kim, Young; Kanne, David; Leong, Meredith; Zeng, Qi; Sen, Rupashree; Amstrong, Todd; Drake, Charles; Dubensky, Thomas; Pardoll, Drew; Gadkare, Shekhar Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Development of mutome-specific personalized vaccines for pancreatic cancer. (7th November 2013) Authors: Lutz, Eric; Kinkead, Heather; Yager, Allison; Armstrong, Todd; Lauer, Peter; Brockstedt, Dirk; Dubensky, Thomas; Jaffee, Elizabeth Journal: Journal for immunotherapy of cancer Issue: Volume 1(2013)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines. (7th November 2013) Authors: Leong, Meredith; Kanne, David; Glickman, Laura; Lemmens, Edward; Lauer, Peter; Metchette, Ken; Burdette, Dara; Diner, Elie; Fu, Juan; Soares, Kevin; Brockstedt, Dirk; Portnoy, Daniel; Vance, Russell; Kim, Young; Jaffee, Elizabeth; Pardoll, Drew; Dubensky, Thomas Journal: Journal for immunotherapy of cancer Issue: Volume 1(2013)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas. Issue 2 (December 2015) Authors: Crittenden, Marka; Bahjat, Keith; Li, Rui; Gore, Pankaj; Fountain, Chris; Hanson, Bill; Skoble, Justin; Lauer, Peter; Murphy, Aimee; Dubensky, Thomas; Brockstedt, Dirk; Urba, Walter Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas. (4th November 2015) Authors: Crittenden, Marka; Bahjat, Keith S; Li, Rui; Gore, Pankaj; Fountain, Chris; Hanson, Bill; Skoble, Justin; Lauer, Peter; Murphy, Aimee L; Dubensky, Thomas; Brockstedt, Dirk G; Urba, Walter Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗